IPP Bureau
World’s first clinical trial for a rare headache disorder
By IPP Bureau - September 15, 2021
The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022
Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis
By IPP Bureau - September 14, 2021
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
.png "NHS UK gives green light to a company to detect early-stage cancer by a simple blood test"){kind=logo}
NHS UK gives green light to a company to detect early-stage cancer by a simple blood test
By IPP Bureau - September 14, 2021
Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025
.jpg "ICMR to use drones for vaccine delivery")
ICMR to use drones for vaccine delivery
By IPP Bureau - September 14, 2021
ICMR receives conditional exemption from Drone Rules 2021 to speed up vaccine delivery in the A&N Islands, Manipur and Nagaland
.jpg "US FDA grants Emergency Use Authorisation for Covid-19 pooled samples")
US FDA grants Emergency Use Authorisation for Covid-19 pooled samples
By IPP Bureau - September 14, 2021
Visby Medical’s instrument-free PCR test to detect the SARS-CoV-2 virus can now be used to pool up to five patient samples using a single test
Aster MIMS Kottakal has a new wing for women and children
By IPP Bureau - September 14, 2021
It has been built at a cost of Rs 19.5 crores through internal accruals of the Malabar Institute of Medical Sciences (MIMS)
Laurus Labs, Unitaid and Clinton Health Access Initiative to develop HIV medication for children
By IPP Bureau - September 14, 2021
Laurus will be incentivised for a portion of its development and commercialisation costs. CHAI will also provide technical and regulatory support to enable accelerated generic development
.jpg "BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer")
BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer
By IPP Bureau - September 14, 2021
In several trials like Celestial (double-blind phase III trial), Phase III Meteor trials, Cabozantinib has shown better PFS (Progression-Free Survival).
Prevest DenPro Limited's IPO to open on BSE SME platform on September 15
By IPP Bureau - September 14, 2021
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
ENTOD Pharma launches surgical division HyTek
By IPP Bureau - September 14, 2021
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
CSIR-NEERI transfers Saline Gargle RT-PCR technology to the MSME ministry
By IPP Bureau - September 13, 2021
This low-cost and highly reliable technology will help in increasing testing in rural and tribal areas
Precision care Ethos therapy debuts in Taiwan
By IPP Bureau - September 13, 2021
Incorporating multi-modality image guidance, Ethos therapy provides the ability to personalize the patient's treatment based on their anatomy and position at the time of treatment
Boehringer Ingelheim and Twist Bioscience ink antibody discovery collaboration
By IPP Bureau - September 13, 2021
Research collaboration covers multiple antibody research programs
Zydus Cadila seeks approval for a two-dose ZyCoV-D Covid-19 vaccine
By IPP Bureau - September 13, 2021
The three-dose vaccine approved for EUA contains 2mg for each dose, whereas the two-dose plan will have 3mg in each dose.
Shalby Hospital opens its first orthopaedic and joint replacement franchisee in Udaipur, Rajasthan
By IPP Bureau - September 13, 2021
The hospital through its network performs more than 10,000 joint replacement surgeries annually
